Skip to the page

Data / Medical devices / United States / Sonoma Pharmaceuticals, Inc.

Sonoma Pharmaceuticals, Inc.: FDA-registered device maker in Boulder, CO, United States, 14 510(k) clearances

Sonoma Pharmaceuticals, Inc. is registered with the FDA (registration 3004554409) in Boulder, CO, United States. It lists 3 device types. The FDA files 14 510(k) clearances under its listings, the newest dated September 13, 2024. 3 recall events name it as the recalling firm. Registered through 2026. FDA data exported November 2, 2026.

SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.

FDA registration number
3004554409
Address
5445 Conestoga Ct Ste 150, Boulder, CO, United States, 80301
Owner or operator
Sonoma Pharmaceuticals Inc. (9063175)
Roles
Complaint file establishment, Manufacturer, Specification developer
First device listed
November 2, 2009
Registered through
2026
Brand names listed
A+D Advanced Dermatitis Care Spray Hydrogel, A+D Antimicrobial Hydrogel Spray, A+D Cleansing & Skin Support Spray, A+D Gentle Face Relief, Advanced Scar & Wound Hydrogel, Alevicyn SG, Aquanil AD Recovery Gel, Aquanil AD Repair Mist and more

Devices it lists

DeviceProduct codeClassRoleSource
Cleanser, Root CanalKJJUManufactureraccessdata.fda.gov
Dressing, Wound, DrugFROUComplaint file establishment, Manufacturer, Specification developeraccessdata.fda.gov
Silicone Hydrogel For Scar ManagementPFP1Manufactureraccessdata.fda.gov

510(k) clearances

The 510(k) numbers this establishment lists, with the FDA decision on each. The applicant is the company that holds the clearance.

Decided510(k) numberDeviceProduct codeDecisionApplicantSource
September 13, 2024K233399Microdacyn Wound Care SolutionFROSubstantially EquivalentSonoma Pharmaceuticals, Inc.accessdata.fda.gov
December 1, 2017K171935Alevicyn SG Antimicrobial GelFROSubstantially EquivalentSonoma Pharmaceuticals, Inc.accessdata.fda.gov
November 21, 2017K172622Microcyn Antimicrobial Skin and Wound CleanserFROSubstantially EquivalentSonoma Pharmaceuticalsaccessdata.fda.gov
November 15, 2017K172851Microcyn Plus Antimicrobial Wound Care SolutionFROSubstantially EquivalentSonoma Pharmaceuticals, Inc.accessdata.fda.gov
July 26, 2017K171727Hydrocleanse Antimicrobial Skin and Wound Care SolutionFROSubstantially EquivalentSonoma Pharmaceuticalsaccessdata.fda.gov
March 23, 2017K162217LOYONFROSubstantially EquivalentOculus Innovative Sciencesaccessdata.fda.gov
April 19, 2016K153648Microcyn Plus Skin and Wound HydrogelFROSubstantially EquivalentOculus Innovative Sciencesaccessdata.fda.gov
December 15, 2015K152945Alevicyn SG Antipruritic GelFROSubstantially EquivalentOculus Innovative Sciencesaccessdata.fda.gov
June 4, 2015K143590Alevicyn SG Antipruritic GelFROSubstantially EquivalentOculus Innovative Sciencesaccessdata.fda.gov
August 18, 2014K141352ENDOCYN ROOT CANAL IRRIGATION SOLUTIONKJJSubstantially EquivalentOculus Innovative Sciencesaccessdata.fda.gov
August 8, 2014K141012HYDROCLEANSE WOUND CARE SOLUTIONFROSubstantially EquivalentOculus Innovative Sciencesaccessdata.fda.gov
November 15, 2013K131672MICROCYN SCAR MANAGEMENT HYDROGELPFPSubstantially EquivalentOculus Innovative Sciencesaccessdata.fda.gov
March 8, 2010K093585MICROCYN SKIN AND WOUND HYDROGELFROSubstantially EquivalentOculus Innovative Sciences, Inc.accessdata.fda.gov
June 2, 2009K090206OCULUS PURACYN ANTIMICROBIAL SKIN AND WOUND CLEANSERFROSubstantially EquivalentOculus Innovative Sciences, Inc.accessdata.fda.gov

Recalls

Recall events where this establishment is the recalling firm, matched on its FEI.

InitiatedEventClassStatusProductReasonSource
November 21, 201675770Class IITerminatedCeramax Skin Barrier Cream: NET WT 0.1 OZ (3 g professional sample - not for retail sale) Under the supervision of a health care professional, Ceramax is intended to be used as a topical skin care preparation to relieve Firm became aware that professional samples of Ceramax are not meeting stability standards set for the product.accessdata.fda.gov
February 12, 201364316Class IITerminatedAtrapro Antipruritic Hydrogel, 1.5 oz gel tube, 4 Net wt/ 1.5 oz.. RX only, Professional Sample, Not for Sale. Pre-printed tube: MS31071, Shelf carton: PL51091-08 Atrapro Antipruritic HydroGel is indicated to manage and Out of specification result - stability test failure of free available chlorine (FAC) which functions as a preservative for the hydrogel. The 13 month test result obtained was 4 ppm FAC and the stability specification is >10 ppm FAC.accessdata.fda.gov
November 9, 201160387Not yet classifiedTerminatedMicrocyn Solution with Preservatives (Rx), 16.9 fl oz (500 mL) and 33.5 fl oz. (990 mL) Ingredients: Electrolyzed Water (99.97%) Sodium Chloride (NaCl) (230 mg/L) and preservatives: Sodium Hypochlorite (Na0Cl) (40 mg/L),Unapproved drug claims and those not approved under 510K clearance.accessdata.fda.gov

Compare with other makers

Updated September 13, 2024. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.